I am pleased to share Pacira BioSciences, Inc.'s fourth quarter and full year 2025 results and to reflect on what was truly a ...
Year Ended December 31, 2025NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results